The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC).
Sergio Vazquez Estevez
No relevant relationships to disclose
Maria Jose Villanueva Silva
No relevant relationships to disclose
Jose Luis Firvida Perez
No relevant relationships to disclose
Martin Lazaro Quintela
No relevant relationships to disclose
Silvia Varela Ferreiro
No relevant relationships to disclose
Gerardo Huidobro Vence
No relevant relationships to disclose
Ovidio Fernandez Calvo
No relevant relationships to disclose
Begona Campos Balea
No relevant relationships to disclose
Joaquin Casal Rubio
No relevant relationships to disclose
Carmen Areses Manrique
No relevant relationships to disclose